Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Madrigal Pharmaceuticals Inc. (MDGL)

87.88   1.46 (1.69%) 10-21 16:00
Open: 87.53 Pre. Close: 86.42
High: 88.3292 Low: 85.39
Volume: 95,544 Market Cap: 1333M
Madrigal Pharmaceuticals Inc is a company focused on the development of novel compounds for the treatment of cardiovascular-metabolic diseases and nonalcoholic steatohepatitis (NASH).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 88.412 - 88.841 88.841 - 89.211
Low: 84.376 - 84.865 84.865 - 85.288
Close: 87.136 - 87.906 87.906 - 88.572

Technical analysis

as of: 2019-10-21 4:37:22 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 110.35     One year: 119.14
Support: Support1: 82.31    Support2: 68.48
Resistance: Resistance1: 94.48    Resistance2: 102.00
Pivot: 86.86
Moving Average: MA(5): 87.22     MA(20): 87.12
MA(100): 93.91     MA(250): 112.75
MACD: MACD(12,26): -1.60     Signal(9): -1.89
Stochastic oscillator: %K(14,3): 55.74     %D(3): 52.33
RSI: RSI(14): 47.59
52-week: High: 219.61  Low: 82.31  Change(%): -55.5
Average Vol(K): 3-Month: 19404  10-Days: 11377

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
MDGL has closed below upper band by 28.3%. Bollinger Bands are 65.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to MDGL's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

The Daily Biotech Pulse: Arbutus Halts Hepatitis B Study, Positive Readout For MEI Pharma's Blood Cancer Drug, Ovid Offering
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week lows on Oct. 3) Aprea Therapeutics Inc (NASDAQ: APRE ) (IPOed on Thursday) Viela Bio Incn (NASDAQ: VIE ) (IPOed on Thursday) Down In The Dumps (Biotech stocks hitting 52-week lows on Oct. 3) Adamas Pharmaceuticals Inc (NASDAQ: ADMS ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) Alpine Immune Sciences Inc (NASDAQ: ALPN ) bluebird bio Inc . (NASDAQ: BLUE ) Corvus Pharmaceuticals Inc (NASDAQ: CRVS ) DelMar Pharmaceuticals Inc (NASDAQ: DMP ) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX ) Erytech Pharma SA (NASDAQ: ERYP ) Frequency Therapeutics Inc (NASDAQ: FREQ )(IPOed on Thursday) Fulcrum Therapeutics Inc (NASDAQ: FULC ) Jaguar Health Inc (NASDAQ: JAGX ) Karuna Therapeutics Inc (NASDAQ: KRTX ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) Neuralstem, Inc. (NASDAQ: CUR ) Obseva SA (NASDAQ: OBSV ) Onconova Therapeutics Inc (NASDAQ: ONTX ) RA Medical Systems Inc (NYSE: RMED ) Sierra Oncology Inc (NASDAQ: SRRA ) Titan Pharmaceuticals, Inc. (NASDAQ: TTNP ) Trinity Biotech plc (NASDAQ: TRIB ) Viveve Medical Inc (NASDAQ: VIVE ) Stocks In Focus Arbutus Halts Hepatitis B Drug Study Arbutus Biopharma Corp (NASDAQ: ABUS ) decided to discontinue the development of AB-506, an oral capsid inhibitor, which was being evaluated in a Phase 1a/1b trial for the treatment …

Madrigal, Galmed, And Galectin In Phase 3 NASH: The Need For Therapeutic Diversity
No summary available.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 15.43
Shares Float (M) 6.28
% Held by Insiders 11.33
% Held by Institutions 97.08
Shares Short (K) 2560
Shares Short P. Month (K)

Stock Financials

EPS -3.570
Book Value (p.s.) 29.620
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -8.7
Return on Equity (ttm) -11.6
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -4.310
Qtrly Earnings Growth
Operating Cash Flow (M) -29.52
Levered Free Cash Flow (M) -12.56

Stock Valuations

P/E -24.62
P/E Growth Ratio 0.02
P/BV 2.97
P/CF -45.93

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2016-07-25
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.